PROSTATE CANCER METASTATIC
Clinical trials for PROSTATE CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Zapping just a few spots: new hope for patients with worsening metastatic cancer?
Disease control OngoingThis study tests whether using highly focused radiation (SBRT) on a limited number of growing cancer spots can help control the disease in patients with metastatic breast or genito-urinary cancers. Instead of switching to a new drug when some tumors start growing, doctors will ta…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo shows promise for rare, aggressive prostate cancer
Disease control OngoingThis study tests a combination of two drugs, pembrolizumab and lenvatinib, in people with a rare and aggressive form of prostate cancer called neuroendocrine prostate cancer that has spread. The goal is to see if this treatment can slow or stop tumor growth. About 45 participants…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New pill shows promise against tough prostate cancer
Disease control OngoingThis study tests an experimental drug called ARV-766, taken as a pill, in men with prostate cancer that has spread to other parts of the body. The drug is given alone or with another medicine (abiraterone) to see if it is safe and can slow the cancer. About 152 men will take part…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can zapping all spots of prostate cancer delay progression? PLATON trial aims to find out
Disease control OngoingThis phase 3 trial is testing whether adding local ablative therapy (radiation or surgery) to all visible cancer sites, on top of standard hormone therapy, improves outcomes for men with hormone-sensitive prostate cancer that has spread to a few spots (oligometastatic). About 409…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug ST101 takes on Hard-to-Treat cancers
Disease control OngoingThis study tests an experimental drug called ST101 in people with advanced solid tumors that cannot be removed by surgery or have spread. The trial includes cancers like glioblastoma, melanoma, breast, and prostate cancer. It aims to find a safe dose and see if the drug can shrin…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Sapience Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New radioactive drug takes aim at Hard-to-Treat prostate cancer
Disease control ENROLLING_BY_INVITATIONThis study tests a new radioactive drug, 177Lu-HTK03170, designed to seek out and destroy prostate cancer cells that have spread. It is for men with metastatic castration-resistant prostate cancer whose disease has worsened after other treatments. The trial will first find a safe…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a special PET scan better track prostate cancer?
Diagnosis OngoingThis study is testing whether a type of PET scan called PSMA PET is more accurate than standard scans (like CT or bone scans) for monitoring prostate cancer. About 58 men with progressive prostate cancer will receive an injection of a radioactive tracer and then undergo PET/CT im…
Matched conditions: PROSTATE CANCER METASTATIC
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 26, 2026 13:17 UTC
-
AI reads biopsies to predict cancer spread
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing whether artificial intelligence can predict if prostate cancer has spread to lymph nodes or other parts of the body by analyzing biopsy tissue images. Researchers will use samples from 3,000 men to develop and validate the AI model. The goal is to help docto…
Matched conditions: PROSTATE CANCER METASTATIC
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC